Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in surgical patients with stage I-IV colorectal cancer (CRC).-MedSci.cn

Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in surgical patients with stage I-IV colorectal cancer (CRC).

Cao, D; Wang, FL; Li, C; Zhang, RX; Wu, XJ; Li, LR; Lu, ZH; Pan, ZZ; Lin, JZ; Wu, MQ; Liu, YF; Lv, GZ; Li, M; Wang, CY; Li, X; Chen, G

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (): 213

科室
- - 订阅+
  - 更多科室
工具
服务